Lv3
300 积分 2024-04-06 加入
The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis
5天前
已完结
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
21天前
已完结
Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
1个月前
已完结
Validation and utility of HepG2 xenograft model for hepatocellular carcinoma
1个月前
已完结
Singling out the immune-suppressive TME in prostate cancer
3个月前
已完结
327 Humanized mouse models for characterizing growth and tissue infiltration of luciferase-expressing AML cell lines
4个月前
已完结
PRAME expression and its prognostic significance in invasive breast carcinoma
4个月前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
4个月前
已完结
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
4个月前
已完结
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
4个月前
已完结
皖公网安备34019202002308
